Interpersonal Psychotherapy in Adolescents With Polycystic Ovary Syndrome
- Conditions
- Interpersonal PsychotherapyPolycystic Ovary Syndrome
- Interventions
- Behavioral: Interpersonal Psychotherapy
- Registration Number
- NCT06056453
- Lead Sponsor
- University of Colorado, Denver
- Brief Summary
The main purpose of this study is to find out whether taking part in a group-based interpersonal psychotherapy (IPT) program designed to improve mood and lessen stress in girls with PCOS will improve depression, unhealthy eating behaviors, weight, and insulin resistance.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 30
- Diagnosed with PCOS duration > 3 months
- 12-17 years old
- BMI > 75th percentile
- CESD > 16
- Weekly or bi-weekly therapy with licensed behavioral health provider
- Inability to speak, read, or write in English (teen)
- Major medical conditions
- HbA1c > 7.0%
- Hormonal contraception < 3 months
- Metformin < 3 months
- Antidepressants/psychotropic medications < 4 weeks
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description IPT Interpersonal Psychotherapy Participate in IPT 6-week intervention group.
- Primary Outcome Measures
Name Time Method Center for Epidemiologic Studies-Depression Scale 6-Month Follow-Up Assessment Depression symptoms will be assessed by the Center for Epidemiologic Studies-Depression Scale. Scores range from 1 to 4. The scoring of positive items is reversed. Possible range of scores is zero to 60, with the higher scores indicating the presence of more symptomatology.
- Secondary Outcome Measures
Name Time Method Emotional Eating Scale Adapted for Children Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment Disordered eating will be assessed by the Emotional Eating Scale Adapted for Children. The scale has been adapted for children and assesses eating in response to negative affect, such as feeling sad or irritated. The scale ranges from "I have no desire to eat" to "I have a very strong desire to eat" and averages how many days a week the participant eats based on that feeling.
BMI Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment Fasting BMI (kg/m2) will be derived from measured height in triplicate by stadiometer and measured fasting weight by calibrated digital scale. BMI z-score and BMI %ile will be computed to determine eligibility (BMI ≥75th percentile).
Insulin Resistance Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment Blood will be sampled via a venipuncture procedure following a 10-hour overnight fast to measure fasting insulin. Insulin resistance will be estimated from fasting insulin and glucose with the homeostatic model assessment of insulin resistance (HOMA-IR).
Loss-of-Control Eating Disorder Questionnaire Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment Loss-of-control eating will be assessed via the 19-item Loss-of-Control Eating Disorder Questionnaire (LOC-ED-Q), which shows sound psychometric properties in adolescents using Yes/No.
Dysglycemia Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment Blood will be sampled via a venipuncture procedure following a 10-hour overnight fast to measure fasting insulin. Insulin resistance will be estimated from fasting insulin and glucose with the homeostatic model assessment of insulin resistance (HOMA-IR).
Reward Based Eating Drive Scale Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment Reward based eating will be assessed by the Reward Based Eating Drive Scale. This is a self-report questionnaire which assesses reward-based eating that shows sound psychometric properties. The total score is summed at the end; a higher total is indicative of reward-based eating.
Dyslipidemia Baseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment Blood will be sampled via a venipuncture procedure following a 10-hour overnight fast to measure dyslipidemia. Insulin resistance will be estimated from fasting insulin and glucose with the homeostatic model assessment of insulin resistance (HOMA-IR).
Trial Locations
- Locations (1)
Children's Hospital Colorado
🇺🇸Aurora, Colorado, United States